In addition, we found HMGA2 knockdown increased CD24+ CD44+ breast cancer in moderate HMGA2 expressed cell line and increased CD24+ CD44- in HMGA2 overexpressed cell lines. This evidence concerns the gene CD44 and breast carcinoma.